A Randomized, Placebo-Controlled Trial Assessing the Effect of VISBIOME ES Probiotic in People With HIV on Antiretroviral Therapy.
Rachel M PrestiEunice YehBrett WilliamsAlan LandayJeffrey M JacobsonCara WilsonCarl J FichtenbaumNetanya S UtayMichael P DubeKarin L KlingmanJacob D EstesJacob K FlynnAmanda LoftinJason M BrenchleyAdriana AndradeDouglas W KitchEdgar Turner OvertonPublished in: Open forum infectious diseases (2021)
Visbiome ES was safe and altered the microbiome but demonstrated no effect on systemic inflammatory markers, pathology, or gut permeability in antiretroviral therapy-treated people with HIV.